Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
A Phase II study of the safety and efficacy of teriflunomide in multiple sclerosis with relapses.
Clinical Reasoning: Left hemiparesis, ataxia, and optic neuritis in a child previously treated for pineoblastoma.
Sema4A inhibits the therapeutic effect of IFN-β in EAE.
Child Neurology Society 41st Annual Meeting
Clinical and neuroradiological differences of paediatric acute disseminating encephalomyelitis with and without antibodies to the myelin oligodendrocyte glycoprotein.
Implications of Real-world Adherence on Cost-effectiveness Analysis in Multiple Sclerosis.
Novantrone
Changes in cognition, arm function and lower body function after Slow-Release Fampridine treatment.
Detailed results from Biogen Idec and AbbVie's pivotal Phase 3 DECIDE study further define the efficacy and safety profile of ZINBRYTA™ (daclizumab high-yield process)
Some recent advances in multiple sclerosis.
Pushing Forward: Remyelination as the New Frontier in CNS Diseases.
Avonex drug warning letter, severe hypatic injury
[Neurophysiology in Guillain-Barré syndrome].
A Multiple-Dose, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group QT/QTc Study to Evaluate the Electrophysiologic Effects of THC/CBD Spray.
European Medicines Agency accepts Marketing Authorization Application for conditional approval of masitinib in the treatment of pancreatic cancer
Understanding the Role of T Cells in CNS Homeostasis.
Predictors and dynamics of postpartum relapses in women with multiple sclerosis.
[Information processing speed and influential factors in multiple sclerosis].
Chronic mild stress eliminates the neuroprotective effect of Copaxone after CNS injury.
Myelinating satellite oligodendrocytes are integrated in a glial syncytium constraining neuronal high-frequency activity.
Improvements in cognition, quality of life, and physical performance with clinical Pilates in multiple sclerosis: a randomized controlled trial.
Clobetasol promotes remyelination in a mouse model of neuromyelitis optica.
Clinically isolated syndromes.
CLIPPERS complicating multiple sclerosis causing concerns of CNS lymphoma.
Tolerability and pharmacokinetics of delayed-release dimethyl fumarate administered with and without aspirin in healthy volunteers.
Pages
« first
‹ previous
…
75
76
77
78
79
80
81
82
83
…
next ›
last »